Antiepileptic treatment in paediatric oncology - An interdisciplinary challenge

Klinische Padiatrie

Volumn 218, Issue 6, 2006, Pages 340-349

  Tibussek, Daniel ^a   Distelmaier, F ^a   Schonberger S ^a   Gobel U ^a   Mayatepek, E ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Antiepileptic drugs; Cancer; Drug interaction; Seizures

Indexed keywords

ALTRETAMINE; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ASPARAGINASE; BUSULFAN; CARBOPLATIN; CARMUSTINE; CHLORAMBUCIL; CLOBAZAM; CLONAZEPAM; CORTICOSTEROID; CYTARABINE; DACARBAZINE; ERYTHROPOIETIN; ETIRACETAM; ETOPOSIDE; FLUDARABINE; FLUOROURACIL; GABAPENTIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IFOSFAMIDE; INTERFERON; INTERLEUKIN 2; LEVAMISOLE; LORAZEPAM; METHOTREXATE; MITOTANE; PENTOSTATIN; UNINDEXED DRUG;

APHASIA; APLASTIC ANEMIA; BONE MARROW TOXICITY; BRAIN TOXICITY; BRAIN TUMOR; CANCER; CENTRAL NERVOUS SYSTEM INFECTION; CEREBRAL BLINDNESS; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; COMA; COMORBIDITY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DOSE RESPONSE; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; ENDOCRINE DISEASE; GENETIC HETEROGENEITY; HEMIPARESIS; HUMAN; HYPERSENSITIVITY; LONG TERM CARE; METABOLIC ENCEPHALOPATHY; NEUROTOXICITY; PROPHYLAXIS; RASH; REVIEW; RISK FACTOR; SEIZURE; STEVENS JOHNSON SYNDROME; THROMBOCYTOPENIA;

ADOLESCENT; AGE FACTORS; AMINES; ANTICONVULSANTS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CHILD; CYCLOHEXANECARBOXYLIC ACIDS; DRUG INTERACTIONS; EPILEPSY; GAMMA-AMINOBUTYRIC ACID; HUMANS; NEOPLASMS; PIRACETAM; RECURRENCE; RISK FACTORS; SAFETY; TIME FACTORS;

EID: 33845243707     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-942257     Document Type: Review

References (78)

1. Aldenkamp AP, De Krom M, Reijs R. Newer antiepileptic drugs and cognitive issues. Epilepsia 2003; 44 (Suppl 4): 21-29
2. rd edn. Lippincott Williams & Wilkins, Philadelphia 2004; 369
3. Beaumont A, Whittle IR. The pathogenesis of tumor associated epilepsy. Acta Neurochir 2000; 142: 1-15
4. Bhatia S. Cancer survivorship - pediatric issues. Hematology (Am Soc Hematol Educ Program) 2005; 1: 507-515
5. Biton V. Effect of antiepileptic drugs on bodyweight: overview and clinical implications for the treatment of epilepsy. CNS Drugs 2003; 17: 781-791
6. Blackburn SC, Oliart AD, Garcia Rodriguez LA, Perez Gutthann S. Antiepileptics and blood dyscrasias: a cohort study. Pharmacotherapy 1998; 18: 1277-1283
7. Bourg V, Lebrun C, Chichmanian RM, Thomas P, Frenay M. Nitrosourea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity. Ann Oncol 2001; 12: 217-219
8. Brickell K, Porter D, Thompson P. Phenytoin toxicity due to fluoropyrimidines (5FU/capecitabine): three case reports. Br J Cancer 2003; 89: 615-616
9. Brodie MJ, French JA. Management of epilepsy in adolescents and adults. Lancet 2000; 356: 323-329
10. Bug G, Ritter M, Wassmann B, Schoch C et al. Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia. Cancer 2005; 104: 2717-2725
11. Chalk JB, Ridgeway K, Brophy T, Yelland JD, Eadie MJ. Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients. J Neurol Neurosurg Psychiatry 1984; 47: 1087-1090
12. Chan KW, Mullen CA, Worth LL, Choroszy M, Koontz S, Tran H, Slopis J. Lorazepam for seizure prophylaxis during high-dose busulfan administration. Bone Marrow Transplant 2002; 29: 963-965
13. Crawford P. Interactions between antiepileptic drugs and hormonal contraception. CNS Drugs 2002; 16: 263-272
14. Crawford P. Best practice guidelines for the management of women with epilepsy. Epilepsia 2005; 46 (Suppl 9): 117-124
15. Creutzig U, Hannemann J, Kramer I, Zimmermann M, Herold R, Marx JF. The "quality house pediatric oncology" as an instrument for improving the performance of the trial centers. Klin Padiatr 2005; 217: 114-119
16. De La Camara R, Tomas JF, Figuera A, Berberana M, Fernandez-Ranada JM. High dose busulfan and seizures. Bone Marrow Transplant 1991; 7: 363-364
17. DiMario FJ, Packer RJ. Acute mental status changes in children with systemic cancer. Pediatrics 1990; 85: 353-360
18. Farwell JR, Lee YJ, Hirtz DG et al. Phenobarbital for febrile seizures - effects on in telligence and on seizure recurrence. N Engl J Med 1990; 322: 364-369
19. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks Jr WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught Jr RE, Sachdeo RC, Beydoun A, Glauser TA. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004; 62: 1252-1260
20. Gieron MA, Barak LS, Estrada J. Severe encephalopathy associated with ifosfamide administration in two children with metastatic tumors. J Neurooncol 1988; 6: 29-30
21. Gilliam FG, Fessier AJ, Baker G, Vahle V, Carter J, Attarian H. Systematic screening allows reduction of adverse antiepileptic drug effects. Neurology 2004; 62: 23-27
22. Ghosh C, Lazarus HM, Hewlett JS, Creger RJ. Fluctuation of serum PHT concentrations during autologous bone marrow transplant for primary central nervous system tumors. J Neurooncol 1992; 12: 25-32
23. Ghosn M, Carde P, Leclerq B, Flamant F, Friedman S, Droz JP, Hayat M. Ifosfamide/mesna related encephalopathy: a case report with a possible role of phenobarbital in enhancing neurotoxicity. Bull Cancer 1988; 75: 391-392
24. Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, Grossman SA, Cairncross JG. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 54: 1886-1893
25. Glauser TA, Ayala R, Elterman RD, Mitchell WG, Van Orman CB, Gauer LJ, Lu Z. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 2006; 66: 1654-1660
26. Grossman SA, Sheidler VR, Gilbert MR. Decreased phenytoin levels in patients receiving chemotherapy. Am J Med 1989; 87: 505-510
27. Guerrini R. Epilepsy in children. Lancet 2006; 367: 499-524
28. Hartmann O. Ifosfamide induced encephalopathy: 15 observations. Arch Pediatr 2006; 13: 140-145
29. Hassan M, Oberg G, Bjorkholm M, Wallin I, Lindgren M. Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics. Cancer Chemother Pharmacol 1993; 33: 181-186
30. Hildebrand J. Management of epileptic seizures. Curr Opin Oncol 2004; 16: 314-317
31. Hindley D, Ali A, Robson C. Diagnoses made in a secondary care "fits, faints, and funny turns" clinic. Arch Dis Child 2006; 91: 214-218
32. Ikeda H, Murakami T, Takano M, Usui T, Kihira K. Pharmacokinetic interaction on valproic acid and recurrence of epileptic seizures during chemotherapy in an epileptic patient. Br J Clin Pharmacol 2005; 59: 593-597
33. Isojarvi JI. Reproductive dysfunction in women with epilepsy. Neurology 2003; 61 (6 Suppl 2): S27-S34
34. Junck L. Supportive management in neuro-oncology: opportunities for patient care, teaching, and research. Curr Opin Neurol 2004; 17: 649-653
35. Keime-Guibert F, Napolitano M, Delattre JY. Neurological complications of radiotherapy and chemotherapy. J Neurol 1998; 245: 695-708
36. Khan RB, Hunt DL, Boop FA, Sanford RA, Merchant TE, Gajjar A, Kun LE. Seizures in children with primary brain tumors: incidence and long-term outcome. Epilepsy Res 2005; 64: 85-91
37. Khan RB, Onar A. Seizure Recurrence and Risk Factors after Antiepilepsy Drug Withdrawal in Children with Brain Tumors. Epilepsia 2006; 47: 375-379
38. Kieslich M, Porto L, Lanfermann H, Jacobi G, Schwabe D, Bohles HJ. Cerebrovascular complications of L-asparaginase in the therapy of acute lymphoblastic leukemia. Pediatr Hematol Oncol 2003; 25: 484-487
39. Kilickap S, Cakar M, Onal IK, Tufan A, Akoglu H, Aksoy S, Erman M, Tekuzman G. Nonconvulsive Status Epilepticus Due to Ifosfamide. Ann Pharmacother 2006; 40: 332-335
40. Lackner TE. Interaction of dexamethasone with phenytoin. Pharmacotherapy 1991; 11: 344-347
41. Laurence V, Gbolade BA, Morgan SJ, Glaser A. Contraception for teenagers and young adults with cancer. Eur J Cancer 2002; 40: 2705-2716
42. Lawson LA, Blouin RA, Smith RB, Rapp RP, Young AB. Phenytoin- dexamethasone interaction: a previously unreported observation. Surg Neurol 1981; 16: 23-24
43. Langebrake C, Uhlenbrock S, Ritter J, Groll AH. Drug interactions of antimicrobial agents in children with cancer. Klin Padiatr 2005; 217 (Suppl 1): S165-S174
44. Loring DW, Meador KJ. Cognitive side effects of antiepileptic drugs in children. Neurology 2004; 62: 872-877
45. Maytal J, Grossman R, Yusuf FH, Shende AC, Karayalycin G, Lanzkowsky P, Schaul N, Eviatar L. Prognosis and treatment of seizures in children with acute lymphoblastic leukemia. Epilepsia 1995; 36: 831-836
46. Meador KJ, Loring DW, Vahle VJ, Ray PG, Werz MA, Fessier AJ, Ogrocki P, Schoenberg MR, Miller JM, Kustra RP. Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers. Neurology 2005; 64: 2108-2114
47. Micali G, Linthicum K, Han N, West DP. Increased risk of erythema multiforme major with combination anticonvulsant and radiation therapies. Pharmacotherapy 1999; 19: 223-227
48. Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology 2005; 64: 1134-1138
49. Ney GC, Lantos G, Barr WB, Schaul N. Cerebellar atrophy in patients with long term PHT exposure and epilepsy. Arch Neurol 1994; 51: 767-771
50. Nicolao P, Giometto B. Neurological toxicity of ifosfamide. Oncology 2003; 65 (Suppl 2): 11-16
51. Oberndorfer S, Piribauer M, Marosi C, Lahrmann H, Hitzenberger P, Grisold W. P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neurooncol 2005; 72: 255-260
52. Ochs JJ, Bowman WP, Pui C-H et al. Seizures in childhood lymphoblastic leukemia patients. Lancet 1984; 2: 1422-1424
53. Orbach D, Brisse H, Doz F. Central neurological manifestations during chemotherapy in children. Arch Pediatr 2003; 10: 533-539
54. Pelgrims J, De Vos F, Van den Brande J, Schrijvers D, Prove A, Vermorken JB. Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature. Br J Cancer 2000; 82: 291-294
55. Plotkin SR, Wen PY. Neurologic complications of cancer therapy. Neurol Clin 2003; 21: 279-318
56. Primavera A, Audenino D, Cocito L. Ifosfamide encephalopathy and nonconvulsive status epilepticus. Can J Neurol Sci 2002; 29: 180-183
57. Quinn CT, Griener JC, Bottiglieri T, Hyland K, Farrow A, Kamen BA. Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for treatment of cancer. J Clin Oncol 1997; 15: 2800-2806
58. Quinn CT, Griener JC, Bottiglieri T, Hyland K, Farrow A, Kamen BA. Methotrexate, homocysteine and seizures. J Clin Oncol 1998; 16: 393-394
59. Relling MV, Pui CH, Sandlund JT, Rivera GK, Hancock ML, Boyett JM, Schuetz EG, Evans WE. Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia. Lancet 2000; 356: 285-290
60. Rosenow F, Hamer HM, Knake S, Katsarou N, Fritsch B, Oertel WH, Shiratori K, Luders HO. Lateralizing and localizing signs and symptoms of epileptic seizures: significance and application in clinical practice. Nervenarzt 2001; 72: 743-749
61. Rüegg S. Dexamethasone/phenytoin interactions: neurooncological concerns. Swiss Med Wkly 2002; 132: 425-426
62. Ruffmann C, Bogliun G, Beghi E. Epileptogenic drugs: a systematic review. Expert Rev Neurother 2006; 6: 575-589
63. Sankar R. Initial treatment of epilepsy with antiepileptic drugs: pediatric issues. Neurology 2004; 63 (Suppl 4): S30-S39
64. Schroder H, Ostergaard JR. Interference of high-dose methotrexate in the metabolism of valproate? Pediatr Hematol Oncol 1994; 11: 445-449
65. Schwarer AP, Opat SS, Watson AL, Cole-Sinclair MF. Clobazam for seizure prophylaxis during busulfan chemotherapy. Lancet 1995; 346: 1238
66. Serkova NJ, Christians U, Benet LZ. Biochemical mechanisms of cyclosporine neurotoxicity. Mol Interv 2004; 4: 97-107
67. Siemes H, Brandi U, Helmstadter C, Kurlemann G, Rating D, Salke-Kellermann RA, Stephani U, Uberall M, Wiemer-Kruel A, Bergmann L. Optimizing epilepsy therapy in children and adolescents with lamotrigine. Klin Padiatr 2005; 217: 222-229
68. Sirven JL, Wingerchuk DM, Drazkowski JF, Lyons MK, Zimmerman RS. Seizure Prophylaxis in Patients With Brain Tumors: A Meta-analysis. Mayo Clin Proc 2004; 79: 1489-1494
69. Sperling MR, Ko J. Seizures and brain tumors. Semin Oncol 2006; 33: 333-341
70. Stevens GH. Antiepileptic therapy in patients with central nervous system malignancies. Curr Neurol Neurosci Rep 2006; 6: 311-318
71. Tomson T, Perucca E, Battino D. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy. Epilepsia 2004; 45: 1171-1175
72. Uldall P, Alving J, Hansen LK, Kibaek M, Buchholt J. The misdiagnosis of epilepsy in children admitted to a tertiary epilepsy centre with paroxysmal events. Arch Dis Child 2006; 91: 219-221
73. Vassal G, Deroussent A, Hartmann O, Challine D, Benhamou E, Valteau-Couanet D, Brugieres L, Kalifa C, Gouyette A, Lemerle J. Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological study. Cancer Res 1990; 50: 6203-6207
74. Vecht CJ, Wagner GL, Wilms EB. Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol 2003; 2: 404-409
75. Verstappen CC, Heimans JJ, Hoekman K, Postma TJ. Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs 2003; 63: 1549-1563
76. Winick NJ, Bowman WP, Kamen BA, Roach ES, Rollins N, Jacaruso D, Buchanan GR. Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia. J Natl Cancer Inst 1992; 84: 252-256
77. Wong DD, Longenecker RG, Liepman M, Baker S, LaVergne M. Phenytoin-dexamethasone: a possible drug-drug interaction. JAMA 1985; 254: 2062-2063
78. Zupanc ML. Antiepileptic drugs and hormonal contraceptives in adolescent women with epilepsy. Neurology 2006; 66 (Suppl 3): S37-S45